UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation

The pharmacogenomics journal, 2003-01, Vol.3 (1), p.53-61

2003

Volltextzugriff (PDF)

Role of CYP2C9 polymorphism in losartan oxidation

Drug metabolism and disposition, 2001-07, Vol.29 (7), p.1051

2001

Volltextzugriff (PDF)

Pharmacogenetics of cyclophosphamide in patients with hematological malignancies

European journal of pharmaceutical sciences, 2006, Vol.27 (1), p.54-61

2006

Volltextzugriff (PDF)

The karolinska cocktail for phenotyping of five human cytochrome P450 enzymes

Clinical pharmacology and therapeutics, 2003-06, Vol.73 (6), p.517-528

2003

Volltextzugriff (PDF)

Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CΥP2C9 genotype

Clinical pharmacology and therapeutics, 2002, Vol.71 (1), p.89

2002

Volltextzugriff (PDF)

Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish Population

Biochemical and biophysical research communications, 1999-01, Vol.254 (3), p.628-631

1999

Volltextzugriff (PDF)

CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers

European journal of clinical pharmacology, 2003-07, Vol.59 (3), p.221-225

2003

Volltextzugriff (PDF)

Oxidation of celecoxib by polymorphic cytochrome P4502C9 and alcohol dehydrogenase

British journal of clinical pharmacology, 2002-10, Vol.54 (4), p.423

2002

Volltextzugriff (PDF)

Changes in cardiac troponin I (cTnI), T (cTnT), and some biochemical parameters in Arabian racehorses after training

South African Journal of Animal Science, 2023-01, Vol.53 (1), p.1-6

2023

Volltextzugriff (PDF)

The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro

European journal of clinical pharmacology, 2001-12, Vol.57 (10), p.729-735

2001

Volltextzugriff (PDF)

Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes

European journal of clinical pharmacology, 2003-06, Vol.59 (2), p.103-109

2003

Volltextzugriff (PDF)

Genetic polymorphisms of cytochrome P450 2C9 causing reduced phenprocoumon (S)-7-hydroxylation in vitro and in vivo

Xenobiotica, 2004-09, Vol.34 (9), p.847-859

2004

Volltextzugriff (PDF)

Analysis of CYP2C95 in Caucasian, Oriental and Black-African populations

European journal of clinical pharmacology, 2002-11, Vol.58 (8), p.555-558

2002

Volltextzugriff (PDF)

Ketobemidone is a substrate for cytochrome P4502C9 and 3A4, but not for P-glycoprotein

Xenobiotica, 2005-08, Vol.35 (8), p.785-796

2005

Volltextzugriff (PDF)

Intra-individual variability in urinary losartan oxidation ratio, an in vivo marker of CYP2C9 activity

British journal of clinical pharmacology, 2002-08, Vol.54 (2), p.183-185

2002

Volltextzugriff (PDF)

Genetic polymorphisms of cytochrome P4502C9 causing reduced phenprocoumon ( S )-7-hydroxylation in vitro and in vivo

Xenobiotica, 2004-09, Vol.34 (9), p.847

2004

Volltextzugriff (PDF)

Enzyme kinetics for the formation of 3-hydroxyquinine and three new metabolites of quinine in vitro; 3-hydroxylation by CYP3A4 is indeed the major metabolic pathway

Drug metabolism and disposition, 2002-12, Vol.30 (12), p.1368-1371

2002

Volltextzugriff (PDF)

Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk

Carcinogenesis (New York), 2002-04, Vol.23 (4), p.665-665

2002

Volltextzugriff (PDF)

Does celecoxib inhibit agomelatine metabolism via CYP2C9 or CYP1A2?

Drug design, development and therapy, 2018-01, Vol.12, p.2169-2172

Yasar, Umit

2018

Volltextzugriff (PDF)

Use of Pyracantha coccinea Roem. as a possible biomonitor for the selected heavy metals

International journal of environmental science and technology (Tehran), 2010, Vol.7 (3), p.427-434

2010

Volltextzugriff (PDF)

Relationship between genetic polymorphisms of drug efflux transporter MDR1 (ABCB1) and response to losartan in hypertension patients

European review for medical and pharmacological sciences, 2016-06, Vol.20 (11), p.2460

2016

Volltextzugriff (PDF)

Cyclophosphamide induces mRNA, protein and enzyme activity of cytochrome P450 in rat

Xenobiotica, 2005-03, Vol.35 (3), p.239-251

2005

Volltextzugriff (PDF)

Magnetic resonance imaging contrast agent related pulmonary edema: a case report

European review for medical and pharmacological sciences, 2012-10, Vol.16 Suppl 4, p.110

2012

Volltextzugriff (PDF)

Is a routine preoperative rectosigmoidoscopy necessary in patients with bilateral inguinal hernia?

Bratislava Medical Journal, 2012-01, Vol.113 (10), p.604-606

2012

Volltextzugriff (PDF)

Negotiation and Coordination in Carpooling: Agent-Based Simulation Model

Transportation research record, 2016, Vol.2542 (1), p.92-101

2016

Volltextzugriff (PDF)

1 – 25 von 351

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(312)
Mit Volltextzugriff
(271)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(241)
Life Sciences & Biomedicine
(160)
Humans
(113)
Male
(91)
Female
(82)
Technology
(65)
Biological And Medical Sciences
(62)
Adult
(59)
Middle Aged
(58)
Medical Sciences
(55)
Computer Science
(47)
Computer Science, Theory & Methods
(39)
Pharmacology & Pharmacy
(39)
Computer Science, Information Systems
(37)
Information Science & Library Science
(35)
Aged
(34)
Medicin Och Hälsovetenskap
(32)
Pharmacology. Drug Treatments
(28)
Adolescent
(24)
Physical Sciences
(23)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation

Role of CYP2C9 polymorphism in losartan oxidation

Pharmacogenetics of cyclophosphamide in patients with hematological malignancies

The karolinska cocktail for phenotyping of five human cytochrome P450 enzymes

Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CΥP2C9 genotype

Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish Population

CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers

Oxidation of celecoxib by polymorphic cytochrome P4502C9 and alcohol dehydrogenase

Changes in cardiac troponin I (cTnI), T (cTnT), and some biochemical parameters in Arabian racehorses after training

The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro

Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes

Genetic polymorphisms of cytochrome P450 2C9 causing reduced phenprocoumon (S)-7-hydroxylation in vitro and in vivo

Analysis of CYP2C95 in Caucasian, Oriental and Black-African populations

Ketobemidone is a substrate for cytochrome P4502C9 and 3A4, but not for P-glycoprotein

Intra-individual variability in urinary losartan oxidation ratio, an in vivo marker of CYP2C9 activity

Genetic polymorphisms of cytochrome P4502C9 causing reduced phenprocoumon ( S )-7-hydroxylation in vitro and in vivo

Enzyme kinetics for the formation of 3-hydroxyquinine and three new metabolites of quinine in vitro; 3-hydroxylation by CYP3A4 is indeed the major metabolic pathway

Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk

Does celecoxib inhibit agomelatine metabolism via CYP2C9 or CYP1A2?

Use of Pyracantha coccinea Roem. as a possible biomonitor for the selected heavy metals

Relationship between genetic polymorphisms of drug efflux transporter MDR1 (ABCB1) and response to losartan in hypertension patients

Cyclophosphamide induces mRNA, protein and enzyme activity of cytochrome P450 in rat

Magnetic resonance imaging contrast agent related pulmonary edema: a case report

Is a routine preoperative rectosigmoidoscopy necessary in patients with bilateral inguinal hernia?

Negotiation and Coordination in Carpooling: Agent-Based Simulation Model

Suchergebnisse filtern